ECG
AZN icon

Edge Capital Group’s AstraZeneca AZN Stock Holding History

Edge Capital Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$9.42M Sell
71,921
-84
-0.1% -$11.8K 0.42% 53
2024
Q3 		$11.2M Sell
72,005
-146
-0.2% -$23.6K 0.5% 43
2024
Q2 		$11.3M Buy
72,151
+1,833
+3% +$276K 0.54% 40
2024
Q1 		$9.53M Buy
70,318
+684
+1% +$90.6K 0.47% 50
2023
Q4 		$9.38M Sell
69,634
-499
-0.7% -$64.9K 0.52% 45
2023
Q3 		$9.5M Sell
70,133
-2,212
-3% -$302K 0.62% 36
2023
Q2 		$10.4M Sell
72,345
-2,860
-4% -$421K 0.59% 40
2023
Q1 		$10.4M Sell
75,205
-5,876
-7% -$791K 0.64% 39
2022
Q4 		$11M Sell
81,081
-1,460
-2% -$183K 0.77% 32
2022
Q3 		$9.05M Buy
82,541
+716
+0.9% +$90.8K 0.74% 32
2022
Q2 		$10.8M Sell
81,825
-1,303
-2% -$171K 0.93% 24
2022
Q1 		$11M Sell
83,128
-1,598
-2% -$192K 0.76% 31
2021
Q4 		$9.87M Sell
84,726
-970
-1% -$114K 0.7% 30
2021
Q3 		$10.3M Sell
85,696
-2,872
-3% -$334K 0.82% 26
2021
Q2 		$10.6M Buy
88,568
+30,288
+52% +$3.32M 0.85% 25
2021
Q1 		$5.79M Buy
+58,280
New +$5.86M 0.49% 51

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Edge Capital Group's AZN Position: Q4 2024 in Review

Edge Capital Group reduced its AstraZeneca (AZN) stake by 0.12% in Q4 2024, selling an estimated $11.8K and leaving 71,921 shares worth $9.42M. The position accounts for 0.42% of the portfolio, ranked #53.

Edge Capital Group first reported a position in AZN in Q1 2021 and has held it in 16 quarters since. The position peaked at $11.3M in Q2 2024. 1,218 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Edge Capital Group held 71,921 shares of AstraZeneca worth $9.42M as of Q4 2024.
  • Edge Capital Group sold 84 AstraZeneca shares in Q4 2024, an estimated $11.8K.
  • AstraZeneca made up 0.42% of Edge Capital Group's portfolio in Q4 2024, its #53 holding.
  • Edge Capital Group first reported a position in AstraZeneca in Q1 2021 and has held it in 16 quarters since.
  • Edge Capital Group's AstraZeneca position peaked at $11.3M in Q2 2024.
  • 1,218 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Edge Capital Group's 13F filing for Q4 2024, filed 4 Feb 2025.